OncoArendi Therapeutics - Announcement of the results of procedure No. 46/2021, DUBs

OncoArendi Therapeutics - Announcement of the results of procedure No. 46/2021, DUBs.

Subject of the contract: Research service consisting in examining the impact of our relationship on 100 cell lines with a diverse genetic profile and origin (representing different types of cancer) in order to assess the genetic profile conditioning the resistance / sensitivity of the oncological model (tumor line) on the functioning of our compound and bioinformatics analysis of genetic differences between the sensitive and resistant groups.

The Commission informs that in this request for proposal the Contractor has not been selected - no bid has been received within the prescribed period.

Contact:

Phone: [phone]

E: [e-mail]

E: [e-mail]

(C) 2022 Electronic News Publishing, source ENP Newswire